Leah Lawrence

1.15 (95% CI, 1.02-1.29) for a 1.0 mg/kg dose vs a 0.5 mg/kg dose 1.43 (95% CI, 1.05-1.96) for a 2.0 mg/kg dose vs a 0.5 mg/kg dose

Certain patients diagnosed with chronic lymphocytic leukemia (CLL) will have their disease monitored for changes instead of starting treatment right away.

The clinical benefit rate was 40% in patients who received a waiver and 33% in those who did not.

Researchers used artificial intelligence and social media to identify barriers to cancer care for transgender patients. The findings were published in

Prostate cancer patients treated with second-generation antiandrogens may have an increased risk of falls, fatigue, and

Individuals with a genetic predisposition to celiac disease have an increased risk for nephropathy and chronic glomerulonephritis, as well as a

ASCO has released its first clinical practice guideline focused specifically on the management of locally advanced rectal cancer. 1 “Rectal cancer, and especially locally advanced rectal cancer, is a complex disease that requires individualized approaches using multimodality therapies to have the best oncologic outcomes for our patients,” said Expert Panel Co-Chair Sepideh Gholami, MD, MAS, of Northwell Health, who explained that recent advances have made management more complex than ever.

— The approval of lazertinib/amivantamab gives clinicians one more option

— TKIs are the first-line of defense, but "the more options we have the better," expert says

Several members of Harvard's Program on Regulation, Therapeutics, and Law recently published a perspective in the New England Journal of Medicine